4TOYOHIRA H, NAKAMURA K, KARIYAZONO H. Significance of combined use of anticoagulants and antiplatelet agents in the early stage after prosthetic valve replacement [ J ]. KyobuGeka, 1995, 48 (9): 749-755.
5SADOWSKI J A, RUSSELL R M. The interaction between vitamin K nutriture and warfarin administration in patients with bacterial overgrowth due to atrophic gastritis [J ]. Nutr Health Aging, 1998, 2 (2): 73-78.
6DAHM M, LOTZ J, HAFINER G, et al. Value of molecular markers for ad ministration of anticoagulant therapy after heart valve replace-ment[J]. Z Kardiol, 1998, 87 (Suppl 14): 42.
7CUSHMAN M, BOOTH S L, POSSIDENTE C J. The association of vitamin Ksiatus with warfarin sensitivity at the onset of treatment[J]. Br Haematol, 2001, 112 (3) : 572- 577.
8BACH A U, ANDERSON S A, FOLEY A L, et al. Assessment of vitamin K status in human subjects administered “minidose” warfarin[J]. Am ClinNutr, 1996, 64 (6): 894- 902.
9SHIMODAIRA H, TAKAHASHI K, KANO K. Enhancement ofanticoagulant action by warfarin-benzbromarone interaction [J]. Clin Pharmacol, 1996, 36 (2) : 168-174.
10Shesrer MJ. Vitamin K: Its physiological role and the assessment of clinical subclinical deficienct state. JIFCC, 1995,7: 88.
